- Acquired by Dilon Technologies, Apr 2020
- Raised $12.3M funding round, Jul 2017
- Raised $21M funding round led by Apax Partners, Oct 2014
About
Dune Medical Devices has developed tissue characterization technology that can be used for a broad range of diagnostic and therapeutic applications and offers surgeons and radiologists the ability to detect cancer in real time. The company's MarginProbe System delivers real-time cancer detection in the operating room through a simple assessment of the margin of excised tissue. The key element of the MarginProbe System is its Fringe Field Sensor. Positioned at the tip of the probe, the highly responsive sensor emits a precisely controlled electromagnetic field and captures the tissue's response. The sensor identifies signals in close range to the edge of the tissue, the critical focus of margin assessment. The company is also developing a smart biopsy system. The system will expand the company's surgical oncology portfolio to include a soft tissue biopsy system with its first indication in breast tissue. This project has received funding from the European Union's Horizon 2020 research and innovation program.
Funding history · 6 rounds · $53.8M total
Q&A
- What is Dune Medical Devices' primary focus?
- Dune Medical Devices specializes in real-time cancer detection through tissue characterization technology, offering surgeons and radiologists the ability to detect cancer in real time.
- What is the MarginProbe System?
- The MarginProbe System by Dune Medical Devices provides real-time cancer detection in the operating room by assessing the margin of excised tissue using a Fringe Field Sensor.
- When was Dune Medical Devices acquired and by whom?
- Dune Medical Devices was acquired by Dilon Technologies in April 2020.
- What is Dune Medical Devices developing in addition to its current offerings?
- Dune Medical Devices is developing a smart biopsy system to expand its surgical oncology portfolio, with an initial indication for breast tissue. This project received funding from the European Union's Horizon 2020 program.
- What was the total amount raised by Dune Medical Devices before its acquisition?
- Dune Medical Devices raised a total of $53,800,000.
- Which investors participated in Dune Medical Devices' October 2014 funding round?
- In October 2014, Dune Medical Devices received funding from investors including.
- What was the most recent funding round for Dune Medical Devices?
- The most recent funding round for Dune Medical Devices occurred in July 2017, with participation from Canepa Healthcare.
- Where is Dune Medical Devices headquartered?
- Dune Medical Devices is headquartered in Caesarea, Israel, with an additional office in Alpharetta, GA, USA.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/80980 | |
| facebook.com/marginprobe | |
| YouTube | youtube.com/channel/UCSHOZXTrhOjiqQgWrhVp7-A |
Identifiers & details
| Founded | 2002-1 |
|---|---|
| Employees (exact) | 20 |
| Offices | Alpharetta |
| Status reason | Acquired (Inactive) by Dilon Technologies on Apr 2020 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Dilon Technologies 2020-04
Radar intelligence
Patents
| EPO | 35 |
|---|